SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Rich Wolf who wrote (3693)1/14/2000 3:02:00 AM
From: Larry Brubaker  Respond to of 4140
 
Rich, touting more turds, I see. Who in the world is going to subject themselves to and pay for laser eye surgery that wears off after a few months?



To: Rich Wolf who wrote (3693)1/14/2000 8:31:00 AM
From: BostonView  Respond to of 4140
 
>>``This is a huge boon to the company,' said Lehman Brothers analyst Kenneth Goldman, who estimated Sunrise's revenues could top $22 million this year and $68 million in 2001 if the FDA approves the laser. Sunrise estimates that 37 million Americans have low to moderate hyperopia.<<

Let's not forget to add lasic correction surgery, off-label use, and future expanded diopter range approval.

Game over for shorts.

BV


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News